Literature DB >> 23667109

Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection.

Torben Knuschke1, Viktoriya Sokolova, Olga Rotan, Munisch Wadwa, Matthias Tenbusch, Wiebke Hansen, Peter Staeheli, Matthias Epple, Jan Buer, Astrid M Westendorf.   

Abstract

The ability of vaccines to induce T cell responses is crucial for preventing diseases caused by viruses or bacteria. Nanoparticles (NPs) are considered an efficient tool for inducing potent immune responses. In this study, we describe a novel vaccination approach with biodegradable calcium phosphate (CaP) NPs that serve as carrier of immunoactive TLR9 ligand (CpG) combined with a viral Ag from the influenza A virus hemagglutinin. Functionalized CaP NPs were efficiently taken up by dendritic cells in vivo and elicited a potent T cell-mediated immune response in immunized mice with high numbers of IFN-γ-producing CD4(+) and CD8(+) effector T cells. Most importantly, both i.p. and intranasal immunization with these NPs offered protection in a mouse model of influenza virus infection. This study demonstrates the great potential of CaP NPs as a novel vaccination tool that offers substantial flexibility for several infection models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23667109     DOI: 10.4049/jimmunol.1202654

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunization.

Authors:  Torben Knuschke; Matthias Epple; Astrid M Westendorf
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

Review 2.  Regulations of organism by materials: a new understanding of biological inorganic chemistry.

Authors:  Jiake Lin; Xiaoyu Wang; Ruikang Tang
Journal:  J Biol Inorg Chem       Date:  2019-06-07       Impact factor: 3.358

3.  A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.

Authors:  Xiaofang Huang; Aykan Karabudak; Joseph D Comber; Mohan Philip; Tulin Morcol; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

4.  Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.

Authors:  Wenqian Tao; Brett L Hurst; Akhilesh Kumar Shakya; Md Jasim Uddin; Rohan S J Ingrole; Mayra Hernandez-Sanabria; Ravi P Arya; Lynn Bimler; Silke Paust; E Bart Tarbet; Harvinder Singh Gill
Journal:  Antiviral Res       Date:  2017-02-02       Impact factor: 5.970

Review 5.  Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections.

Authors:  Tejabhiram Yadavalli; Deepak Shukla
Journal:  Nanomedicine       Date:  2016-08-26       Impact factor: 5.307

Review 6.  Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.

Authors:  Robert K DeLong; Chandler B Curtis
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-06-16

7.  Calcium phosphate nanoparticles show an effective activation of the innate immune response in vitro and in vivo after functionalization with flagellin.

Authors:  Diana Kozlova; Viktoriya Sokolova; Maohua Zhong; Ejuan Zhang; Jingyi Yang; Wei Li; Yi Yang; Jan Buer; Astrid Maria Westendorf; Matthias Epple; Huimin Yan
Journal:  Virol Sin       Date:  2013-12-26       Impact factor: 4.327

Review 8.  Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.

Authors:  Lampouguin Yenkoidiok-Douti; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2020-01-12

9.  Small Wonders-The Use of Nanoparticles for Delivering Antigen.

Authors:  Aya Taki; Peter Smooker
Journal:  Vaccines (Basel)       Date:  2015-08-10

10.  Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells.

Authors:  Alexander J Vogel; Deborah M Brown
Journal:  Front Immunol       Date:  2015-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.